Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Inspection Goals Reduced After Shutdown; Review Dates Look Safe
Feb 27 2019
•
By
Michael McCaughan
US FDA is going to miss its inspection targets after the partial government shutdown.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance